Comparing Amisulpride vs Aprepitant
| Amisulpride | Aprepitant |
|
|---|
| Amisulpride | Aprepitant |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Schizophrenia, Persistent Depressive Disorder, Nausea/Vomiting - Postoperative. Amisulpride may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting, Nausea/Vomiting - Postoperative. Aprepitant may also be used for purposes not listed in this medication guide. |
Related suggestions Nausea/Vomiting, Postoperative
|
|||||||
| More about Amisulpride | More about Aprepitant | ||||||||
| Ratings & Reviews | |||||||||
|
Amisulpride has an average rating of 8.3 out of 10 from a total of 16 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 6% reported a negative effect. |
Aprepitant has an average rating of 8.0 out of 10 from a total of 18 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Amisulpride side effects |
View all Aprepitant side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Aprepitant prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Barhemsys | Aponvie, Cinvanti, Emend | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
12 hours |
13 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 391 drugs are known to interact with Amisulpride:
|
A total of 448 drugs are known to interact with Aprepitant:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
February 26, 2020 |
March 26, 2003 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.